Buy Excel Crop, says Sharmila Joshi of Fairwealth Securities.
Joshi told CNBC-TV18, "Buy Excel Crop. The stock has corrected significantly post the negative news on Endosulfan. But now the buzz is that the supreme court may lift the ban on Enfosulfan and excel crop could benefit tremendously from this because the product form big part of portfolio almost 40%. So I buy this with a target of Rs 198 with a stop loss of Rs 190, do keep the stock on your radar for this development."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!